Saturday 17 October 2026
Export CSLT’s income statement to Excel — free account
Castlight Health, inc.
CSLT Healthcare Health Information Services
Operating cash flow growth for ten consecutive years.
2.05
0.00
0.00%
Follow CSLT
| Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 2 | 4 | 3 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.34 | 1.35 | 1.91 | 3.61 | 5.05 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(7.62) | (3.56) | (1.45) | (1.05) | (4.11) |
P/Operating CF |
66.55 | 48.37 | 39.81 | (5,962.86) | (291.78) |
Beneish M-Score |
(4.14) | (2.71) | (2.60) | 0.43 | (3.29) |
P/B ratio |
1.59 | 1.12 | 1.53 | 2.25 | 4.89 |
Price to Tangible BV |
2.65 | 2.80 | 3.45 | 4.79 | 4.89 |
EV/Sales |
1.11 | 1.00 | 1.44 | 2.94 | 3.89 |
EV/EBITDA |
30.29 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(29.17) | (8.21) | (12.11) | (16.57) | (10.40) |
EV/FCF |
(17.75) | (7.38) | (10.93) | (14.95) | (9.94) |
Quick Ratio |
2.36 | 1.65 | 2.04 | 2.02 | 2.66 |
Current Ratio |
2.47 | 1.74 | 2.11 | 2.09 | 2.89 |
Net Debt/EBITDA |
(9.19) | 2.95 | 4.88 | 2.39 | 2.45 |
Debt/Assets |
0.00% | 0.57% | 1.28% | 1.77% | 0.00% |
Debt/Equity |
0.00 | 0.01 | 0.02 | 0.02 | 0.00 |
Asset Turnover |
0.72 | 0.58 | 0.59 | 0.60 | 0.60 |
Operating CF/Net income |
0.09 | 0.43 | 0.47 | 0.45 | 0.63 |
Capex/Depreciation |
(0.05) | (0.09) | (0.08) | (0.12) | (0.14) |
| (41.91%) | (21.77%) | (19.55%) | (33.11%) | (53.27%) | |
| (30.37%) | (16.12%) | (14.89%) | (23.75%) | (35.52%) | |
ROIC |
(52.59%) | (22.50%) | (20.68%) | (29.29%) | 0.00% |
Return on Tangible Assets |
(111.46%) | (88.07%) | (65.51%) | (76.87%) | (60.15%) |
Average Days of Receivables |
78.97 | 79.97 | 62.58 | 60.64 | 54.75 |
Research and Development Expense of Revenue |
33.72% | 41.17% | 39.23% | 41.28% | 40.99% |
Selling, General and Administrative Expense of Revenue |
39.32% | 46.46% | 47.80% | 67.10% | 86.62% |
Intangible Assets out of Total Assets |
0.30 | 0.43 | 0.43 | 0.40 | 0.00 |
Share Based Compensation of Revenue |
8.48% | 10.47% | 11.59% | 18.18% | 21.53% |
Graham Net Nets |
0.21 | 0.13 | 0.16 | 0.11 | 0.17 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(32.31%) | (20.30%) | (13.36%) | (11.84%) | (11.92%) |
Free Cash Flow Yield |
(4.64%) | (10.02%) | (6.88%) | (5.45%) | (7.75%) |
Revenue per Share |
0.97 | 0.99 | 1.14 | 1.05 | 0.98 |
Operating CF per Share |
(0.04) | (0.12) | (0.13) | (0.19) | (0.37) |
Capex per Share |
(0.02) | (0.01) | (0.01) | (0.02) | (0.02) |
Free Cash Flow per Share |
(0.06) | (0.13) | (0.15) | (0.21) | (0.38) |
Cash per Share |
0.33 | 0.41 | 0.56 | 0.74 | 1.14 |
Shareholders Equity per Share |
0.82 | 1.19 | 1.41 | 1.69 | 1.01 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.82 | 1.19 | 1.41 | 1.69 | 1.01 |
Free Cash Flow |
(9.14) | (19.34) | (20.56) | (26.00) | (38.67) |
Working Capital |
50.47 | 40.56 | 56.65 | 62.26 | 92.29 |
Capital Expenditures |
(3.58) | (1.95) | (2.01) | (2.54) | (1.70) |
Net Current Asset Value |
41.88 | 25.56 | 48.99 | 50.94 | 85.81 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||
Depreciation/Fixed assets |
12.81 | 4.47 | 6.24 | 3.95 | 2.33 |
Cash ROIC |
(5.28%) | (8.28%) | (7.47%) | (8.39%) | (17.86%) |
Accounts Receivable Turnover |
4.65 | 4.92 | 6.42 | 7.19 | 7.16 |
Accounts Payable Turnover |
4.21 | 4.05 | 8.94 | 15.06 | 11.24 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
36.08 | 121.08 | 57.95 | 30.57 | 26.21 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
31.57 | 29.11 | 24.37 | 18.37 | 13.78 |
Average Payables |
12.37 | 14.58 | 6.73 | 3.10 | 2.84 |
Average Assets |
204.78 | 248.15 | 266.70 | 218.52 | 165.22 |
Average Common Equity |
148.37 | 183.77 | 203.11 | 156.76 | 110.16 |
Columns are period end dates